Hodgkin's Lymphoma

Hodgkin's Lymphoma News

  • Alert FDA OKs Pembrolizumab for Classical Hodgkin Lymphoma FDA approval was based on tumor response rate and durability of response. Continued approval may hinge on clinical benefits verified and described in confirmatory trials.
  • Dramatic Rise in Colorectal Cancer in Younger Adults Colorectal cancer rates have risen dramatically among Generation Xers and millenials; researcher warns that repeal of the Affordable Care Act is 'very concerning' for cancer diagnosis.

Hodgkin's Lymphoma Perspective